<DOC>
	<DOC>NCT00240955</DOC>
	<brief_summary>The objective of this study is to assess the long-term safety and tolerability of EC-MPS on the patients who completed the core study and wish to continue treatment on EC-MPS.</brief_summary>
	<brief_title>Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Inclusion Criteria/ Exclusion Criteria All patients who completed the core study and who are still receiving the ECMPS and wish continue treatment with ECMPS and from whom written informed consent has been obtained Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Renal/Kidney, Transplantation, steroids, EC-MPS</keyword>
</DOC>